SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-290149
Filing Date
2020-11-10
Accepted
2020-11-10 16:11:11
Documents
74
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d848036d10q.htm 10-Q 360418
2 EX-31.1 d848036dex311.htm EX-31.1 11253
3 EX-31.2 d848036dex312.htm EX-31.2 11226
4 EX-32 d848036dex32.htm EX-32 6155
11 GRAPHIC g848036g38i71.jpg GRAPHIC 6234
  Complete submission text file 0001193125-20-290149.txt   3493652

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rcel-20200930.xml EX-101.INS 689208
6 XBRL TAXONOMY EXTENSION SCHEMA rcel-20200930.xsd EX-101.SCH 42270
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rcel-20200930_cal.xml EX-101.CAL 46015
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rcel-20200930_def.xml EX-101.DEF 144940
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcel-20200930_lab.xml EX-101.LAB 315643
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcel-20200930_pre.xml EX-101.PRE 252252
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Filer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39059 | Film No.: 201301227
SIC: 3841 Surgical & Medical Instruments & Apparatus